Biomerica, Inc. (BMRA)
NASDAQ: BMRA · IEX Real-Time Price · USD
0.665
-0.015 (-2.18%)
At close: Apr 26, 2024, 4:00 PM
0.690
+0.025 (3.73%)
After-hours: Apr 26, 2024, 4:50 PM EDT
Biomerica Revenue
Biomerica had revenue of $5.41M in the twelve months ending February 29, 2024, down -43.29% year-over-year. Revenue in the quarter ending February 29, 2024 was $1.02M, a -8.46% decrease year-over-year. In the fiscal year ending May 31, 2023, Biomerica had annual revenue of $5.34M, a decrease of -71.71%.
Revenue (ttm)
$5.41M
Revenue Growth
-43.29%
P/S Ratio
2.07
Revenue / Employee
$87,181
Employees
62
Market Cap
11.19M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
May 31, 2023 | 5.34M | -13.53M | -71.71% |
May 31, 2022 | 18.87M | 11.67M | 162.13% |
May 31, 2021 | 7.20M | 506.32K | 7.57% |
May 31, 2020 | 6.69M | 1.49M | 28.69% |
May 31, 2019 | 5.20M | -363.50K | -6.53% |
May 31, 2018 | 5.56M | -227.49K | -3.93% |
May 31, 2017 | 5.79M | 651.85K | 12.68% |
May 31, 2016 | 5.14M | 177.44K | 3.58% |
May 31, 2015 | 4.96M | -158.08K | -3.09% |
May 31, 2014 | 5.12M | -1.35M | -20.89% |
May 31, 2013 | 6.47M | 391.83K | 6.44% |
May 31, 2012 | 6.08M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CareMax | 751.10M |
Cosmos Health | 49.59M |
Biotricity | 11.63M |
iCoreConnect | 8.15M |
Elevai Labs | 1.71M |
Can-Fite BioPharma | 743.00K |
Inhibikase Therapeutics | 260.50K |
China SXT Pharmaceuticals | 29.92K |
BMRA News
- 13 days ago - Biomerica provides update on inFoods® IBS expansion - GlobeNewsWire
- 15 days ago - Biomerica Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 4 weeks ago - Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference - GlobeNewsWire
- 2 months ago - Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board - GlobeNewsWire
- 3 months ago - Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica - GlobeNewsWire
- 3 months ago - Biomerica Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population - GlobeNewsWire
- 6 months ago - Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16 - GlobeNewsWire